Some Bextra Users Are Suffering Severe Side Effects

Kahn Gauthier Swick is investigating claims against pharmaceutical company Pharmacia on behalf of patients who have been prescribed the painkiller Bextra (valdecoxib) and later suffered a hypersensitivity reaction or a severe skin reaction due to taking Bextra. Bextra, a COX-2 inhibitor, was approved by the federal Food and Drug Administration (FDA) on November 16, 2001, and was marketed in March, 2002. Bextra can be prescribed for osteoarthritis, adult rheumatoid arthritis, and primary dysmennorhea.

Stevens-Johnson Syndrome

Stevens-Johnson syndrome (SJS), which is an immune-complex-mediated hypersensitivity complex that is a severe expression of erythema multiforme. SJS typically involves the skin and the mucous membranes. While minor presentations may occur, significant involvement of oral, nasal, eye, vaginal, urethral, GI, and lower respiratory tract mucous membranes may develop in the course of the illness. SJS is a serious systemic disorder with the potential for severe morbidity and even death.

Our claim form will help you with telling us about your potiental claim.